Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist being studied for metabolic disorders. This synthetic peptide has shown promising results in clinical trials for weight management and blood sugar control.
Our facility produces high purity tirzepatide under strict GMP conditions. The white lyophilized powder is carefully packaged to maintain stability and purity. Each batch undergoes rigorous quality control testing including HPLC analysis to verify the 99% purity specification.
The molecular structure of tirzepatide (C225H348N48O68) makes it particularly effective at activating both GIP and GLP-1 receptors. This dual mechanism contributes to its enhanced metabolic effects compared to single-receptor agonists.
When you buy tirzepatide from our facility, you receive pharmaceutical-grade material suitable for research applications. The product is supplied in sealed vials containing precisely measured quantities (5mg, 10mg, 20mg or 30mg) of the active peptide.
Researchers interested in metabolic disorders may find tirzepatide particularly valuable for studying: weight loss mechanisms, glucose homeostasis, insulin sensitivity, and related metabolic pathways. The compound has demonstrated significant effects on body weight reduction in clinical studies.
Our production process ensures batch-to-batch consistency and reliable performance in research settings. The lyophilized powder remains stable when stored properly in cool, dry conditions.
For researchers needing larger quantities, we offer bulk purchasing options and custom synthesis services. Our technical team can provide additional analytical data and documentation upon request when you buy tirzepatide for your research projects.
